ATE527552T1 - Mr-darstellungsverfahren zur diskriminierung zwischen gesundem und tumorgewebe - Google Patents

Mr-darstellungsverfahren zur diskriminierung zwischen gesundem und tumorgewebe

Info

Publication number
ATE527552T1
ATE527552T1 AT05771198T AT05771198T ATE527552T1 AT E527552 T1 ATE527552 T1 AT E527552T1 AT 05771198 T AT05771198 T AT 05771198T AT 05771198 T AT05771198 T AT 05771198T AT E527552 T1 ATE527552 T1 AT E527552T1
Authority
AT
Austria
Prior art keywords
discrimination
healthy
tumor tissue
imaging method
sup
Prior art date
Application number
AT05771198T
Other languages
English (en)
Inventor
Mikkel Thaning
Rene In T Zandt
Original Assignee
Ge Healthcare As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ge Healthcare As filed Critical Ge Healthcare As
Application granted granted Critical
Publication of ATE527552T1 publication Critical patent/ATE527552T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/05—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves
    • A61B5/055—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves involving electronic [EMR] or nuclear [NMR] magnetic resonance, e.g. magnetic resonance imaging
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R33/00—Arrangements or instruments for measuring magnetic variables
    • G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
    • G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
    • G01R33/48—NMR imaging systems
    • G01R33/483—NMR imaging systems with selection of signals or spectra from particular regions of the volume, e.g. in vivo spectroscopy
    • G01R33/485—NMR imaging systems with selection of signals or spectra from particular regions of the volume, e.g. in vivo spectroscopy based on chemical shift information [CSI] or spectroscopic imaging, e.g. to acquire the spatial distributions of metabolites
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0404—Lipids, e.g. triglycerides; Polycationic carriers
    • A61K51/0406—Amines, polyamines, e.g. spermine, spermidine, amino acids, (bis)guanidines
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R33/00—Arrangements or instruments for measuring magnetic variables
    • G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
    • G01R33/28—Details of apparatus provided for in groups G01R33/44 - G01R33/64
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R33/00—Arrangements or instruments for measuring magnetic variables
    • G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
    • G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
    • G01R33/48—NMR imaging systems
    • G01R33/54—Signal processing systems, e.g. using pulse sequences ; Generation or control of pulse sequences; Operator console
    • G01R33/56—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution
    • G01R33/5601—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution involving use of a contrast agent for contrast manipulation, e.g. a paramagnetic, super-paramagnetic, ferromagnetic or hyperpolarised contrast agent

Landscapes

  • Physics & Mathematics (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • High Energy & Nuclear Physics (AREA)
  • Condensed Matter Physics & Semiconductors (AREA)
  • General Physics & Mathematics (AREA)
  • Radiology & Medical Imaging (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Engineering & Computer Science (AREA)
  • Optics & Photonics (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Signal Processing (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pathology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Surgery (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Lasers (AREA)
AT05771198T 2004-07-30 2005-07-28 Mr-darstellungsverfahren zur diskriminierung zwischen gesundem und tumorgewebe ATE527552T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NO20043226 2004-07-30
PCT/NO2005/000282 WO2006011810A2 (en) 2004-07-30 2005-07-28 Mr imaging method for the discrimination between healthy and tumour tissue

Publications (1)

Publication Number Publication Date
ATE527552T1 true ATE527552T1 (de) 2011-10-15

Family

ID=35501891

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05771198T ATE527552T1 (de) 2004-07-30 2005-07-28 Mr-darstellungsverfahren zur diskriminierung zwischen gesundem und tumorgewebe

Country Status (15)

Country Link
EP (1) EP1784227B1 (de)
JP (1) JP5362987B2 (de)
KR (1) KR101126952B1 (de)
CN (2) CN102565735B (de)
AT (1) ATE527552T1 (de)
AU (1) AU2005267669B2 (de)
BR (1) BRPI0513896A (de)
CA (1) CA2576202A1 (de)
ES (1) ES2372058T3 (de)
IL (1) IL180896A (de)
MX (1) MX2007001033A (de)
PL (1) PL1784227T3 (de)
RU (1) RU2369406C2 (de)
WO (1) WO2006011810A2 (de)
ZA (1) ZA200701280B (de)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1954321B1 (de) 2005-12-01 2011-11-23 Ge Healthcare As Verfahren zur dynamischen kernpolarisation (dnp) unter verwendung eines tritylrests und eines paramagnetischen metallions
EP1998813A2 (de) * 2006-03-29 2008-12-10 GE Healthcare AS Verfahren zur herstellung hyperpolaisierter carboxylate und sulfonate in gegenwart von anorganischen kationen
US7202665B1 (en) 2006-04-19 2007-04-10 Wisconsin Alumni Research Foundation Magnetic resonance spectroscopy of species with multiple peaks
EP2051739A2 (de) * 2006-08-18 2009-04-29 GE Healthcare AS Bildgebungsmedium mit laktat und hyperpolarisiertem 13c-pyruvat
ES2381380T3 (es) 2006-08-18 2012-05-25 Ge Healthcare As Formación de imagenes de 13C-RM o de espectroscopia de muerte celular
JP5269791B2 (ja) 2006-08-30 2013-08-21 ジーイー・ヘルスケア・アクスイェ・セルスカプ 動的核分極（ｄｎｐ）方法並びに該方法で使用するための化合物及び組成物
DE602007008452D1 (de) * 2006-10-17 2010-09-23 Ge Healthcare As Verfahren zur herstellung von alpha-keto-säuren und estern davon
WO2008063078A1 (en) * 2006-11-21 2008-05-29 Ge Healthcare As Method for managing patients with cancers
US8812076B2 (en) * 2006-11-21 2014-08-19 General Electric Company Proton decoupled hyperpolarized magnetic resonance imaging
EP2117607A4 (de) 2007-01-11 2012-08-08 Huntington Medical Res Inst Abbildungswirkstoffe und verfahren zu ihrer verwendung
US7470813B2 (en) 2007-03-30 2008-12-30 Ge Healthcare Limited Method for the production of pyruvic acid
US20080242974A1 (en) * 2007-04-02 2008-10-02 Urbahn John A Method and apparatus to hyperpolarize materials for enhanced mr techniques
US7741844B2 (en) * 2007-05-07 2010-06-22 General Electric Company Method and system for magnetic resonance imaging using labeled contrast agents
MX2009011855A (es) * 2007-05-17 2009-11-18 Gen Electric Metodos de calificacion de rm de un tumor utilizando un medio de elaboracion de imagen que comprende 13c-piruvato hiperpolarizado.
WO2009013350A2 (en) * 2007-07-26 2009-01-29 Ge Healthcare Uk Limited Imaging medium comprising hyperpolarised 13 c-lactate and use thereof
AU2008294727B2 (en) * 2007-09-07 2013-10-17 Ge Healthcare Limited Method of determination of PDH activity and imaging media for use in said method
JP5448397B2 (ja) 2007-09-07 2014-03-19 キヤノン株式会社 基質プローブ、多重核磁気共鳴法による酵素活性の検出方法および酵素活性のイメージング方法
EP2902041A1 (de) 2007-12-19 2015-08-05 GE Healthcare Limited Zusammensetzung und Verfahren zur Erzeugung eines metabolischen Profils bei Verwendung von 13C-MR
US20110038804A1 (en) * 2007-12-21 2011-02-17 Anna Gisselsson Mr imaging agent, imaging medium and methods of imaging wherein such an imaging medium is used
CN101932341A (zh) * 2008-02-04 2010-12-29 通用电气健康护理有限公司 Mr成像剂或包含超极化13c-丙氨酸的成像介质和使用该成像介质的成像方法
WO2009129265A1 (en) 2008-04-14 2009-10-22 Huntington Medical Research Institutes Methods and apparatus for pasadena hyperpolarization
US8763410B2 (en) * 2008-04-21 2014-07-01 General Electric Company Method and apparatus for the dissolution and filtration of a hyperpolarized agent with a neutral dissolution media
WO2009133169A1 (en) 2008-05-02 2009-11-05 General Electric Company Method of determining alanine transaminase (alt) activity by 13c-mr detection using hyperpolarised 13c-pyruvate
BRPI1013677A2 (pt) * 2009-04-02 2016-04-26 Ge Healthcare Ltd método para detectar inflamação ou infecção, e, usos de um 13c-piruvato hiperpolarizado, e de um meio de formação de imagem.
EP2476009A1 (de) 2009-09-10 2012-07-18 GE Healthcare UK Limited 13c-mr-detektion mit hyperpolarisierter 13-c-fructose
US9069098B2 (en) 2011-09-09 2015-06-30 Schlumberger Technology Corporation Three or more multiple figure-eight coils for NMR well-logging measurements with azimuthal directional sensitivity
CA2876852C (en) * 2012-06-29 2020-12-22 Cr Development Ab Quantification of the relative amount of water in the tissue microcapillary network
EP2972441B1 (de) * 2013-03-14 2016-11-30 Ecole Polytechnique Fédérale de Lausanne (EPFL) Verfahren zur erzeugung von radikalen für eine dynamische kernspinpolarisierung und anwendungen in der nmr, mrs und mrt
US9874622B2 (en) 2013-09-27 2018-01-23 General Electric Company Hyperpolarized media transport vessel
WO2015055727A1 (en) * 2013-10-15 2015-04-23 Technische Universität München Ph-biosensors based on compounds produced from pyruvic acid for magnetic resonance imaging and spectroscopy and their uses
EP2863229A1 (de) * 2013-10-15 2015-04-22 Technische Universität München pH-Biosensoren auf Basis von Verbindungen mit pH-sensiblen Enolgruppen zur Magnetresonanzbildgebung und Spektroskopie und deren Verwendungen
KR101516634B1 (ko) * 2014-07-09 2015-05-06 연세대학교 산학협력단 13c-자기공명분광영상을 이용한 암 환자의 치료 예후를 예측하는 방법
WO2017147418A1 (en) 2016-02-24 2017-08-31 Ohio State Innovation Foundation Methods and devices for contrast agent magnetic resonance imaging
CN109477872A (zh) * 2016-03-10 2019-03-15 纪念斯隆凯特琳癌症中心 超极化微核磁共振系统和方法
RU2634783C1 (ru) * 2016-07-05 2017-11-03 Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр онкологии имени Н.Н. Петрова" Министерства здравоохранения Российской Федерации Способ дифференциальной диагностики образований молочной железы и мягких тканей
KR101939454B1 (ko) * 2017-03-21 2019-01-16 전남대학교산학협력단 생체 내 과분극화 c13 피루베이트 자기공명분광법을 이용하여 새로운 정량적 생체지표를 통한 비알코올성 지방간질환 진단 방법
US12082918B2 (en) * 2017-11-21 2024-09-10 Solvex Limited Liability Company Preparation for magnetic resonance diagnostics for oncological diseases, comprising deuterated 2-amino-2-methylpropionic acid and/or 2-(N-methylamino)-2-methylpropionic acid, and diagnostic method using said preparation
RU2741212C1 (ru) * 2020-03-12 2021-01-22 Государственное автономное учреждение здравоохранения «Республиканский клинический онкологический диспансер Министерства здравоохранения Республики Татарстан» (ГАУЗ «РКОД МЗ РТ») Способ диагностики злокачественных очаговых образований периферической зоны предстательной железы
RU2749126C1 (ru) * 2020-05-06 2021-06-04 Государственное автономное учреждение здравоохранения «Республиканский клинический онкологический диспансер Министерства здравоохранения Республики Татарстан» (ГАУЗ «РКОД МЗ РТ») Способ дифференциальной диагностики очаговых образований предстательной железы
EP4140505A1 (de) * 2021-08-26 2023-03-01 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Gereinigte signalverstärkte kontrastmittel für die magnetresonanzbildgebung

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01265950A (ja) * 1988-04-15 1989-10-24 Toshiba Corp スペクトロスコピックイメージング装置
DE3920433A1 (de) * 1989-06-22 1991-01-03 Philips Patentverwaltung Kernresonanzabbildungsverfahren
US5323780A (en) * 1992-08-07 1994-06-28 University Of Florida Research Foundation, Inc. Artifact-free imaging contrast agent
US5671741A (en) * 1995-08-04 1997-09-30 The Regents Of The University Of California Magnetic resonance imaging technique for tissue characterization
RU2186405C2 (ru) * 1996-03-29 2002-07-27 Лоренс Беркли Нэшнл Лэборэтори Усиление ядерного магнитного резонанса (ямр) и магниторезонансной визуализации (мрв) в присутствии гиперполяризованных благородных газов
CN1224502A (zh) * 1996-03-29 1999-07-28 劳伦斯·伯克利国家实验室 利用超极化惰性气体对于核磁共振和磁共振成象质量的提高
US6278893B1 (en) * 1998-01-05 2001-08-21 Nycomed Imaging As Method of magnetic resonance imaging of a sample with ex vivo polarization of an MR imaging agent
DE102004011874B4 (de) * 2004-03-11 2006-04-20 Universitätsklinikum Freiburg Verfahren zur Messung der Magnetresonanz (NMR) mittels Continuously Refocused Multiecho Spectroscopic Imaging

Also Published As

Publication number Publication date
MX2007001033A (es) 2007-07-25
EP1784227B1 (de) 2011-10-05
IL180896A (en) 2013-07-31
RU2007102845A (ru) 2008-09-10
CN102565735A (zh) 2012-07-11
CN102565735B (zh) 2016-02-10
WO2006011810A3 (en) 2006-04-13
JP5362987B2 (ja) 2013-12-11
WO2006011810A2 (en) 2006-02-02
HK1107003A1 (en) 2008-03-28
ES2372058T3 (es) 2012-01-13
KR20070061806A (ko) 2007-06-14
AU2005267669B2 (en) 2011-02-24
CA2576202A1 (en) 2006-02-02
KR101126952B1 (ko) 2012-03-20
IL180896A0 (en) 2007-07-04
AU2005267669A1 (en) 2006-02-02
EP1784227A2 (de) 2007-05-16
BRPI0513896A (pt) 2008-05-20
CN101031811A (zh) 2007-09-05
ZA200701280B (en) 2008-09-25
RU2369406C2 (ru) 2009-10-10
PL1784227T3 (pl) 2012-03-30
JP2008508023A (ja) 2008-03-21

Similar Documents

Publication Publication Date Title
IL180896A0 (en) Method of tumour imaging
SI1472541T1 (sl) Prikazovalni agensi in postopek prikazovanja naaladase ali psma
GB0504988D0 (en) Device and method for the treatment of diseased tissue such as tumors
CY2017013I1 (el) ΑΝΤΙΣΩΜΑ ΕΝΑΝΤΙΟΝ PDGFR-α ΓΙΑ ΧΡΗΣΗ ΣΤΗΝ ΘΕΡΑΠΕΥΤΙΚΗ ΑΓΩΓΗ ΟΓΚΩΝ
ZA200409492B (en) Compositions and methods for the diagnosis and treatment of tumor.
EP2468776A3 (de) Antikörper gegen Robo4 und Anwendungen davon
WO2002080754A3 (en) Methods for using annexin for detecting cell death in vivo and treating associated conditions
IL207637A (en) Choosing a Breast Cancer Remedy Using Antibody-Based Arrays
MX2009012625A (es) Metodos para el tratamiento, diagnostico y deteccion de trastornos asociados con el fgf21.
WO2007109236A8 (en) Microrna fingerprints during human megakaryocytopoiesis
EP1723251A4 (de) In-vitro-testsystem zur prognose der verträglichkeit eines patienten gegenüber therapeutika
ATE349446T1 (de) Amyloid plaque aggregationshemmer und diagnostische bilderzeugungsmittel
WO2003087831A3 (en) Proteins involved in breast cancer
BR0306715A (pt) Métodos para diagnóstico e tratamento de tumores
WO2011008696A3 (en) Diagnostic methods and compositions for treatment of cancer
WO2010046900A3 (en) Rgd-containing peptidomimetics and uses thereof
WO2008060945A3 (en) Diagnosis and treatment of breast cancer
WO2009027703A3 (en) Identifying organ damage
WO2004073649A3 (en) Clk-peptide and slk-peptide
WO2007033167A3 (en) Compositions and methods for detecting and treating cancer
WO2011041701A3 (en) Inplantable contrast agents and methods
WO2004087734A3 (en) Stq-peptides
DK1596879T3 (da) Anvendelse af kahalalidforbindelser til fremstilling af et medikament til behandling af psoriasis
DE60030270D1 (de) Fettsaure analoge zur diagnose von kranzarterie erkrankungen
DE60203256D1 (de) System für eine implantierbare medizinische Vorrichtung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties